Health and Pharmaceuticals

Healthcare and life sciences organisations face strict regulatory standards, data obligations and scrutiny over supply chains and clinical integrity.

Overview

Product safety, licensing, marketing practices and data protection are core risks for pharmaceutical, biotech and healthcare providers. Investigations can span pricing, procurement and allegations of bribery or sanctions breaches.

Rapid innovation and international collaboration add layers of legal complexity and reputational exposure.

How We Help

We manage investigations, recalls and parallel regulatory inquiries, coordinating responses across agencies and jurisdictions.

Our team provides strategic advice on compliance frameworks, clinical trial governance, supply chain integrity and crisis communications.

Awards & Honours

“A leading fraud and corporate defence firm. Commended for financial crime and fraud and regulatory.”

The Times Best Law Firms 2026

Tips & Resources

> What A Company Needs To Do To Obtain A Deferred Prosecution Agreement

Deferred prosecution agreements (DPAs) can be an attractive alternative to prosecution for a company that is being investigated for corporate crime.

book